结直肠手术加速康复路径:不用它划算吗?
本研究比较实施加速康复路径(ERP)前后连续结直肠切除患者,ERP 组住院中位时间从 5.0 天降至 3.0 天,30 天并发症与再入院率无差异,总直接费用和直接药费均降低。
要点
- ERP 使结直肠切除术后中位住院时间由 5.0 天降至 3.0 天。
- ERP 未增加 30 天并发症或再入院率,且阿片类药物用量显著减少。
- 尽管日均药费更高,ERP 总直接药费和总直接费用均更低。
核心结论
- 择期结直肠切除实施 ERP 可显著缩短住院时间、降低总医院费用和直接药费,不增加并发症或再入院。
研究设计与样本
- 单中心实施前后对照研究,ERP 前传统组 n=160,ERP 后 n=146,比较短期手术结局、总直接费用和直接医院药费。
主要发现
- ERP 后中位住院时间从 5.0 天降至 3.0 天(p < 0.01)。
- 30 天并发症为 8.1% vs 8.9%,再入院为 11.9% vs 11.0%,均无差异。
- ERP 组住院期间阿片类药物用量显著更少(211.7 vs 720.2 吗啡当量单位;p < 0.01),并提前 1 天耐受常规饮食(p < 0.01)。
- 尽管 ERP 组日均药费更高($477/天 vs $318/天),住院总直接药费更低($1,534 vs $1,859;p = 0.016)。
- ERP 组总直接费用更低($9,791 vs $11,508;p = 0.004)。
临床怎么用
- 择期结直肠切除应常规实施 ERP,以缩短住院时间并降低费用,而不必担心增加并发症或再入院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery pathways (ERPs) aim to reduce length of stay without adversely affecting short-term outcomes. High pharmaceutical costs associated with ERP regimens, however, remain a significant barrier to widespread implementation. We hypothesized that ERP would reduce hospital costs after elective colorectal resections, despite the use of more expensive pharmaceutical agents. STUDY DESIGN: An ERP was implemented in January 2016 at our institution. We collected data on consecutive colorectal resections for 1 year before adoption of ERP (traditional, n = 160) and compared them with consecutive resections after universal adoption of ERP (n = 146). Short-term surgical outcomes, total direct costs, and direct hospital pharmacy costs were compared between patients who received the ERP and those who did not. RESULTS: After implementation of the ERP, median length of stay decreased from 5.0 to 3.0 days (p < 0.01). There were no differences in 30-day complications (8.1% vs 8.9%) or hospital readmission (11.9% vs 11.0%). The ERP patients required significantly less narcotics during their index hospitalization (211.7 vs 720.2 morphine equivalence units; p < 0.01) and tolerated a regular diet 1 day sooner (p < 0.01). Despite a higher daily pharmacy cost ($477 per day vs $318 per day in the traditional cohort), the total direct pharmacy cost for the hospitalization was reduced in ERP patients ($1,534 vs $1,859; p = 0.016). Total direct cost was also lower in ERP patients ($9,791 vs $11,508; p = 0.004). CONCLUSIONS: Implementation of an ERP for patients undergoing elective colorectal resection substantially reduced length of stay, total hospital cost, and direct pharmacy cost without increasing complications or readmission rates. Enhanced recovery pathway after colorectal resection has both clinical and financial benefits. Widespread implementation has the potential for a dramatic impact on healthcare costs.
引用
- Jung AD, Dhar VK, Hoehn RS, et al. Enhanced Recovery after Colorectal Surgery: Can We Afford Not to Use It? J Am Coll Surg. 2018. PMID: 29421693. doi:10.1016/j.jamcollsurg.2017.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。